首页 > 最新文献

Korean Circulation Journal最新文献

英文 中文
Mitral Annular Tissue Velocity Predicts Survival in Patients With Primary Mitral Regurgitation. 二尖瓣环组织速度预测原发性二尖瓣反流患者的存活率
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.4070/kcj.2023.0292
You-Jung Choi, Chan Soon Park, Tae-Min Rhee, Hyun-Jung Lee, Hong-Mi Choi, In-Chang Hwang, Jun-Bean Park, Yeonyee E Yoon, Jin Oh Na, Hyung-Kwan Kim, Yong-Jin Kim, Goo-Yeong Cho, Dae-Won Sohn, Seung-Pyo Lee

Background and objectives: Early diastolic mitral annular tissue (e') velocity is a commonly used marker of left ventricular (LV) diastolic function. This study aimed to investigate the prognostic implications of e' velocity in patients with mitral regurgitation (MR).

Methods: This retrospective cohort study included 1,536 consecutive patients aged <65 years with moderate or severe chronic primary MR diagnosed between 2009 and 2018. The primary and secondary outcomes were all-cause and cardiovascular mortality, respectively. According to the current guidelines, the cut-off value of e' velocity was defined as 7 cm/s.

Results: A total of 404 individuals were enrolled (median age, 51.0 years; 64.1% male; 47.8% severe MR). During a median 6.0-year follow-up, there were 40 all-cause mortality and 16 cardiovascular deaths. Multivariate analysis revealed a significant association between e' velocity and all-cause death (adjusted hazard ratio [aHR], 0.770; 95% confidence interval [CI], 0.634-0.935; p=0.008) and cardiovascular death (aHR, 0.690; 95% CI, 0.477-0.998; p=0.049). Abnormal e' velocity (≤7 cm/s) independently predicted all-cause death (aHR, 2.467; 95% CI, 1.170-5.200; p=0.018) and cardiovascular death (aHR, 5.021; 95% CI, 1.189-21.211; p=0.028), regardless of symptoms, LV dimension and ejection fraction. Subgroup analysis according to sex, MR severity, mitral valve replacement/repair, and symptoms, showed no significant interactions. Including e' velocity in the 10-year risk score improved reclassification for mortality (net reclassification improvement [NRI], 0.154; 95% CI, 0.308-0.910; p<0.001) and cardiovascular death (NRI, 1.018; 95% CI, 0.680-1.356; p<0.001).

Conclusions: In patients aged <65 years with primary MR, e' velocity served as an independent predictor of all-cause and cardiovascular deaths.

背景和目的:舒张早期二尖瓣环组织(e')速度是左心室(LV)舒张功能的常用指标。本研究旨在探讨 e'速度对二尖瓣反流(MR)患者预后的影响:这项回顾性队列研究纳入了 1536 名连续的老年患者:中位年龄 51.0 岁;64.1% 为男性;47.8% 为重度 MR)。在中位 6.0 年的随访期间,共有 40 例全因死亡和 16 例心血管疾病死亡。多变量分析显示,e'速度与全因死亡(调整后危险比 [aHR],0.770;95% 置信区间 [CI],0.634-0.935;P=0.008)和心血管死亡(aHR,0.690;95% CI,0.477-0.998;P=0.049)之间存在显著关联。e'速度异常(≤7 cm/s)可独立预测全因死亡(aHR,2.467;95% CI,1.170-5.200;p=0.018)和心血管死亡(aHR,5.021;95% CI,1.189-21.211;p=0.028),与症状、左心室尺寸和射血分数无关。根据性别、MR 严重程度、二尖瓣置换/修复和症状进行的亚组分析表明,没有显著的交互作用。将e'速度纳入10年风险评分可改善死亡率的再分类(净再分类改善[NRI],0.154;95% CI,0.308-0.910;P结论:对于年龄在
{"title":"Mitral Annular Tissue Velocity Predicts Survival in Patients With Primary Mitral Regurgitation.","authors":"You-Jung Choi, Chan Soon Park, Tae-Min Rhee, Hyun-Jung Lee, Hong-Mi Choi, In-Chang Hwang, Jun-Bean Park, Yeonyee E Yoon, Jin Oh Na, Hyung-Kwan Kim, Yong-Jin Kim, Goo-Yeong Cho, Dae-Won Sohn, Seung-Pyo Lee","doi":"10.4070/kcj.2023.0292","DOIUrl":"10.4070/kcj.2023.0292","url":null,"abstract":"<p><strong>Background and objectives: </strong>Early diastolic mitral annular tissue (e') velocity is a commonly used marker of left ventricular (LV) diastolic function. This study aimed to investigate the prognostic implications of e' velocity in patients with mitral regurgitation (MR).</p><p><strong>Methods: </strong>This retrospective cohort study included 1,536 consecutive patients aged <65 years with moderate or severe chronic primary MR diagnosed between 2009 and 2018. The primary and secondary outcomes were all-cause and cardiovascular mortality, respectively. According to the current guidelines, the cut-off value of e' velocity was defined as 7 cm/s.</p><p><strong>Results: </strong>A total of 404 individuals were enrolled (median age, 51.0 years; 64.1% male; 47.8% severe MR). During a median 6.0-year follow-up, there were 40 all-cause mortality and 16 cardiovascular deaths. Multivariate analysis revealed a significant association between e' velocity and all-cause death (adjusted hazard ratio [aHR], 0.770; 95% confidence interval [CI], 0.634-0.935; p=0.008) and cardiovascular death (aHR, 0.690; 95% CI, 0.477-0.998; p=0.049). Abnormal e' velocity (≤7 cm/s) independently predicted all-cause death (aHR, 2.467; 95% CI, 1.170-5.200; p=0.018) and cardiovascular death (aHR, 5.021; 95% CI, 1.189-21.211; p=0.028), regardless of symptoms, LV dimension and ejection fraction. Subgroup analysis according to sex, MR severity, mitral valve replacement/repair, and symptoms, showed no significant interactions. Including e' velocity in the 10-year risk score improved reclassification for mortality (net reclassification improvement [NRI], 0.154; 95% CI, 0.308-0.910; p<0.001) and cardiovascular death (NRI, 1.018; 95% CI, 0.680-1.356; p<0.001).</p><p><strong>Conclusions: </strong>In patients aged <65 years with primary MR, e' velocity served as an independent predictor of all-cause and cardiovascular deaths.</p>","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"54 6","pages":"311-322"},"PeriodicalIF":2.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11169913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141306198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aneroid Auscultatory Sphygmomanometers and Automated Oscillometric Devices as Mercury-Free Alternatives in Children. 作为儿童无汞替代品的无液体听诊式血压计和自动振荡计。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-01 DOI: 10.4070/kcj.2024.0115
Young Hwan Song
{"title":"Aneroid Auscultatory Sphygmomanometers and Automated Oscillometric Devices as Mercury-Free Alternatives in Children.","authors":"Young Hwan Song","doi":"10.4070/kcj.2024.0115","DOIUrl":"10.4070/kcj.2024.0115","url":null,"abstract":"","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"54 5","pages":"288-290"},"PeriodicalIF":2.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11109841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141065743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Left Atrial Appendage (LAA) Occlusion With Gigantic LAA Using a Custom-Manufactured LAmbre Device. 使用定制的 LAmbre 设备经皮阻塞巨大 LAA 的左心房阑尾(LAA)。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-01 DOI: 10.4070/kcj.2024.0014
Yangyoun Lee, Iksung Cho, Jung-Sun Kim
{"title":"Percutaneous Left Atrial Appendage (LAA) Occlusion With Gigantic LAA Using a Custom-Manufactured LAmbre Device.","authors":"Yangyoun Lee, Iksung Cho, Jung-Sun Kim","doi":"10.4070/kcj.2024.0014","DOIUrl":"10.4070/kcj.2024.0014","url":null,"abstract":"","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"54 5","pages":"291-293"},"PeriodicalIF":2.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11109835/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141065825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiomyocyte Autophagy: A Novel Therapeutic Target by LncRNA PART1. 心肌细胞自噬:LncRNA PART1 的新治疗靶点
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-01 DOI: 10.4070/kcj.2024.0114
Yong Sook Kim
{"title":"Cardiomyocyte Autophagy: A Novel Therapeutic Target by LncRNA PART1.","authors":"Yong Sook Kim","doi":"10.4070/kcj.2024.0114","DOIUrl":"10.4070/kcj.2024.0114","url":null,"abstract":"","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"54 5","pages":"253-255"},"PeriodicalIF":2.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11109836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141065822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Replacing Mercury Sphygmomanometers With Mercury-Free Sphygmomanometers for the National Health Survey in Children: Direct Comparisons Applying Two Types of Mercury-Free Sphygmomanometer. 在全国儿童健康调查中用无汞血压计取代汞血压计:两种无汞血压计的直接比较。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-01 DOI: 10.4070/kcj.2023.0274
Sung Hye Kim, Yu-Mi Kim, Seong Heon Kim, Jinho Shin, Eun Mi Lee

Background and objectives: Blood pressure (BP) measurement using an auscultatory sphygmomanometer is recommended for diagnosing hypertension in children. As mercury sphygmomanometers (MSs) are banned owing to environmental concerns, it is crucial to determine the accuracy of mercury-free sphygmomanometers to replace them. We analyzed the accuracy of these devices to guide the National Survey selection.

Methods: BP was measured thrice each with MS, auscultatory device (AD), and oscillometric device (OD) in 104 participants aged 10-18 using the National Survey data. The difference in BP was defined as the difference between MS and other devices. The BP differences, correlations, and influencing factors were analyzed. The frequencies of hypertension were also compared.

Results: Systolic BP (SBP) and diastolic BP (DBP) differences between MS and AD were 0.88±3.36 mmHg and 0.63±3.95 mmHg, and those between MS and OD were 0.43±5.83 mmHg and 4.57±6.89 mmHg, respectively. The absolute error of <10 mmHg for DBP between MS and OD was 76%. The concordance correlation coefficient between MS and AD was 0.94 for SBP and 0.90 for DBP, and 0.81 and 0.67, respectively for MS and OD. Arm circumference negatively correlated with BP differences except for SBP between the MS and OD. The frequency of hypertension was not different between MS and AD but was underestimated by OD.

Conclusions: AD correlated well with MS, while OD did not, especially for DBP. The superiority of AD over OD suggests AD as a possible alternative for MS in the National Survey.

背景和目的:建议使用听诊式血压计测量血压,以诊断儿童高血压。由于汞血压计(MS)因环境问题而被禁用,因此确定无汞血压计的准确性以取代它们至关重要。我们分析了这些设备的准确性,以指导全国调查的选择:方法:利用全国调查数据,使用无汞血压计、听诊器(AD)和示波器(OD)对 104 名 10-18 岁的参与者进行了三次血压测量。血压差异被定义为 MS 和其他设备之间的差异。对血压差异、相关性和影响因素进行了分析。同时还比较了高血压的发病频率:结果:MS 和 AD 之间的收缩压(SBP)和舒张压(DBP)差值分别为 0.88±3.36 mmHg 和 0.63±3.95 mmHg,MS 和 OD 之间的收缩压(SBP)和舒张压(DBP)差值分别为 0.43±5.83 mmHg 和 4.57±6.89 mmHg。结论的绝对误差AD与MS的相关性良好,而OD则不然,尤其是DBP。AD 优于 OD 表明,在全国调查中,AD 可以替代 MS。
{"title":"Replacing Mercury Sphygmomanometers With Mercury-Free Sphygmomanometers for the National Health Survey in Children: Direct Comparisons Applying Two Types of Mercury-Free Sphygmomanometer.","authors":"Sung Hye Kim, Yu-Mi Kim, Seong Heon Kim, Jinho Shin, Eun Mi Lee","doi":"10.4070/kcj.2023.0274","DOIUrl":"10.4070/kcj.2023.0274","url":null,"abstract":"<p><strong>Background and objectives: </strong>Blood pressure (BP) measurement using an auscultatory sphygmomanometer is recommended for diagnosing hypertension in children. As mercury sphygmomanometers (MSs) are banned owing to environmental concerns, it is crucial to determine the accuracy of mercury-free sphygmomanometers to replace them. We analyzed the accuracy of these devices to guide the National Survey selection.</p><p><strong>Methods: </strong>BP was measured thrice each with MS, auscultatory device (AD), and oscillometric device (OD) in 104 participants aged 10-18 using the National Survey data. The difference in BP was defined as the difference between MS and other devices. The BP differences, correlations, and influencing factors were analyzed. The frequencies of hypertension were also compared.</p><p><strong>Results: </strong>Systolic BP (SBP) and diastolic BP (DBP) differences between MS and AD were 0.88±3.36 mmHg and 0.63±3.95 mmHg, and those between MS and OD were 0.43±5.83 mmHg and 4.57±6.89 mmHg, respectively. The absolute error of <10 mmHg for DBP between MS and OD was 76%. The concordance correlation coefficient between MS and AD was 0.94 for SBP and 0.90 for DBP, and 0.81 and 0.67, respectively for MS and OD. Arm circumference negatively correlated with BP differences except for SBP between the MS and OD. The frequency of hypertension was not different between MS and AD but was underestimated by OD.</p><p><strong>Conclusions: </strong>AD correlated well with MS, while OD did not, especially for DBP. The superiority of AD over OD suggests AD as a possible alternative for MS in the National Survey.</p>","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"54 5","pages":"270-287"},"PeriodicalIF":2.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11109839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141065831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Intertwined Relationship Between Heart Failure and Atrial Fibrillation, How Can We Untangle It? 心力衰竭与心房颤动之间的关系盘根错节,如何才能解开?
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-05-01 DOI: 10.4070/kcj.2024.0099
Ran Heo
{"title":"The Intertwined Relationship Between Heart Failure and Atrial Fibrillation, How Can We Untangle It?","authors":"Ran Heo","doi":"10.4070/kcj.2024.0099","DOIUrl":"10.4070/kcj.2024.0099","url":null,"abstract":"","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"54 5","pages":"268-269"},"PeriodicalIF":2.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11109838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141065836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention. 经皮冠状动脉介入治疗后服用 P2Y12 抑制剂单药 3 个月后,CHADS-P2A2RC 风险评分与临床结果的关系。
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-04-24 DOI: 10.4070/kcj.2023.0268
Pil Sang Song, Seok-Woo Seong, Ji-Yeon Kim, Soo Yeon An, Mi Joo Kim, Kye Taek Ahn, Seon-Ah Jin, Jin-Ok Jeong, Jeong Hoon Yang, Joo-Yong Hahn, Hyeon-Cheol Gwon, Woo Jin Jang, Hyuck Jun Yoon, Jang-Whan Bae, Woong Gil Choi, Young Bin Song
Concerns remain that early aspirin cessation may be associated with potential harm in subsets at high risk of ischemic events. This study aimed to assess the effects of P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) vs. prolonged DAPT (12-month or longer) based on the ischemic risk stratification, the CHADS-P2A2RC, after percutaneous coronary intervention (PCI).
人们仍然担心过早停用阿司匹林可能会对缺血性事件高风险人群造成潜在伤害。本研究旨在评估经皮冠状动脉介入治疗(PCI)后,根据缺血性风险分层(CHADS-P2A2RC)进行为期3个月的双联抗血小板治疗(DAPT)后单用P2Y12抑制剂与延长DAPT(12个月或更长)的效果。
{"title":"The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention.","authors":"Pil Sang Song, Seok-Woo Seong, Ji-Yeon Kim, Soo Yeon An, Mi Joo Kim, Kye Taek Ahn, Seon-Ah Jin, Jin-Ok Jeong, Jeong Hoon Yang, Joo-Yong Hahn, Hyeon-Cheol Gwon, Woo Jin Jang, Hyuck Jun Yoon, Jang-Whan Bae, Woong Gil Choi, Young Bin Song","doi":"10.4070/kcj.2023.0268","DOIUrl":"https://doi.org/10.4070/kcj.2023.0268","url":null,"abstract":"Concerns remain that early aspirin cessation may be associated with potential harm in subsets at high risk of ischemic events. This study aimed to assess the effects of P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) vs. prolonged DAPT (12-month or longer) based on the ischemic risk stratification, the CHADS-P2A2RC, after percutaneous coronary intervention (PCI).","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"21 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140806307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Radiofrequency Catheter Ablation for Atrial Fibrillation on Right Ventricular Function. 射频导管消融术治疗心房颤动对右心室功能的影响
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-04-24 DOI: 10.4070/kcj.2023.0312
Minkwan Kim, Jae-Sun Uhm, Je-Wook Park, SungA Bae, In Hyun Jung, Seok-Jae Heo, Daehoon Kim, Hee Tae Yu, Tae-Hoon Kim, Boyoung Joung, Moon-Hyoung Lee
The effects of radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) on right ventricular (RV) function are not well known.
心房颤动(房颤)射频导管消融术(RFCA)对右心室(RV)功能的影响尚不十分清楚。
{"title":"The Effects of Radiofrequency Catheter Ablation for Atrial Fibrillation on Right Ventricular Function.","authors":"Minkwan Kim, Jae-Sun Uhm, Je-Wook Park, SungA Bae, In Hyun Jung, Seok-Jae Heo, Daehoon Kim, Hee Tae Yu, Tae-Hoon Kim, Boyoung Joung, Moon-Hyoung Lee","doi":"10.4070/kcj.2023.0312","DOIUrl":"https://doi.org/10.4070/kcj.2023.0312","url":null,"abstract":"The effects of radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) on right ventricular (RV) function are not well known.","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"12 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140800760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dronedarone Attenuates Ang II-Induced Myocardial Hypertrophy Through Regulating SIRT1/FOXO3/PKIA Axis. 决奈达隆通过调节 SIRT1/FOXO3/PKIA 轴减轻 Ang II 诱导的心肌肥厚
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-04-24 DOI: 10.4070/kcj.2023.0197
Cheng Chen, Song Hu, Heng-Jing Hu, Zhi-Xuan Liu, Xin-Teng Wu, Tao Zou, Hua Su
Long-term pathological myocardial hypertrophy (MH) seriously affects the normal function of the heart. Dronedarone was reported to attenuate left ventricular hypertrophy of mice. However, the molecular regulatory mechanism of dronedarone in MH is unclear.
长期病理性心肌肥厚(MH)严重影响心脏的正常功能。据报道,决奈达隆可减轻小鼠左心室肥厚。然而,决奈达隆在MH中的分子调控机制尚不清楚。
{"title":"Dronedarone Attenuates Ang II-Induced Myocardial Hypertrophy Through Regulating SIRT1/FOXO3/PKIA Axis.","authors":"Cheng Chen, Song Hu, Heng-Jing Hu, Zhi-Xuan Liu, Xin-Teng Wu, Tao Zou, Hua Su","doi":"10.4070/kcj.2023.0197","DOIUrl":"https://doi.org/10.4070/kcj.2023.0197","url":null,"abstract":"Long-term pathological myocardial hypertrophy (MH) seriously affects the normal function of the heart. Dronedarone was reported to attenuate left ventricular hypertrophy of mice. However, the molecular regulatory mechanism of dronedarone in MH is unclear.","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"19 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140800762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beta Blockers in Contemporary Cardiology: Is It Better to Cast Them Out? 当代心脏病学中的β受体阻滞剂:淘汰它们更好吗?
IF 2.9 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-04-24 DOI: 10.4070/kcj.2023.0209
Javaid Ahmad Dar, John Roshan Jacob
Beta blockers are one of the commonest prescription drugs in medicine and they have been thought to revolutionize the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) in the last century. In addition to HFrEF, they are prescribed for a variety of diseases in cardiology from hypertension to HF, angina, and stable coronary artery disease (CAD). The increased prescription of beta blockers in conditions like HF with preserved ejection fraction (HFpEF), and stable CAD may be doing more harm than good as per the data we have so far. The available data shows that beta blockers are associated with increased stroke risk and atrial fibrillation (AF) in hypertension and in patients with HFpEF, they have been associated with decreased exercise capacity. In patients with stable CAD and patients with myocardial infarction with normal systolic functions, beta blockers don't offer any mortality benefit. In this article, we critically review the common indications and the uses of beta blockers in patients with HFpEF, CAD, hypertension and AF and we propose that beta blockers are over-prescribed under the shadow of their beneficial effects in patients with HFrEF.
β受体阻滞剂是医学界最常见的处方药之一,在上个世纪被认为是治疗射血分数降低型心力衰竭(HF)的革命性药物。除了射血分数降低性心力衰竭(HFrEF),β受体阻滞剂还可用于治疗心脏病学中的各种疾病,包括高血压、心力衰竭、心绞痛和稳定型冠状动脉疾病(CAD)。根据我们目前掌握的数据,在射血分数保留型心房颤动(HFpEF)和稳定型冠状动脉疾病(CAD)等情况下,β受体阻滞剂处方量的增加可能弊大于利。现有数据显示,β受体阻滞剂与高血压患者中风风险增加和心房颤动(AF)有关,而对于射血分数保留的心房颤动(HFpEF)患者,β受体阻滞剂与运动能力下降有关。对于收缩功能正常的稳定型 CAD 患者和心肌梗死患者,β 受体阻滞剂对死亡率没有任何益处。在这篇文章中,我们认真回顾了β受体阻滞剂在高频心衰、冠状动脉硬化、高血压和房颤患者中的常见适应症和用途,并提出在β受体阻滞剂对高频心衰患者有益的阴影下,β受体阻滞剂被过度处方。
{"title":"Beta Blockers in Contemporary Cardiology: Is It Better to Cast Them Out?","authors":"Javaid Ahmad Dar, John Roshan Jacob","doi":"10.4070/kcj.2023.0209","DOIUrl":"https://doi.org/10.4070/kcj.2023.0209","url":null,"abstract":"Beta blockers are one of the commonest prescription drugs in medicine and they have been thought to revolutionize the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) in the last century. In addition to HFrEF, they are prescribed for a variety of diseases in cardiology from hypertension to HF, angina, and stable coronary artery disease (CAD). The increased prescription of beta blockers in conditions like HF with preserved ejection fraction (HFpEF), and stable CAD may be doing more harm than good as per the data we have so far. The available data shows that beta blockers are associated with increased stroke risk and atrial fibrillation (AF) in hypertension and in patients with HFpEF, they have been associated with decreased exercise capacity. In patients with stable CAD and patients with myocardial infarction with normal systolic functions, beta blockers don't offer any mortality benefit. In this article, we critically review the common indications and the uses of beta blockers in patients with HFpEF, CAD, hypertension and AF and we propose that beta blockers are over-prescribed under the shadow of their beneficial effects in patients with HFrEF.","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"240 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140800674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Korean Circulation Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1